Newsletter Archive

  1. 04.18.23 -- AI & Health Disparities: Driving A Wedge Or Closing The Gap? 4/18/2023
    04/18/23 Clinical Leader Newsletter
  2. 04.17.23 -- 2 Strategies For Patient Centricity In Rare Disease Trials 4/17/2023
    04/17/23 Clinical Leader Newsletter
  3. 04.14.23 -- Unlocking The Potential Of RWD In Rare Disease Trials 4/14/2023
    04/14/23 Clinical Leader Newsletter
  4. 04.14.23 -- Progression For Patients Needing Precision Medicine 4/14/2023

    04/14/23 Clinical Leader Newsletter

  5. 04.13.23 -- ICH's New Q9(R1) Guideline On Quality Risk Management: A Primer 4/13/2023
    04/13/23 Clinical Leader Newsletter
  6. 04.12.23 -- Core Outcome Sets: What Are They & Why Are They Needed? 4/12/2023
    04/12/23 Clinical Leader Newsletter
  7. 04.12.23 -- Using Demand-Led Supply And Direct-To-Patient Distribution To Navigate Today's Increasingly Complex Studies 4/12/2023

    04/12/23 Clinical Leader Newsletter

  8. 04.11.23 -- Embracing Change Management To Integrate New Trial Technologies 4/11/2023
    04/11/23 Clinical Leader Newsletter
  9. 04.11.23 -- Supporting Electronic Consent Systems At Study Sites 4/11/2023

    04/11/23 Clinical Leader Newsletter

  10. 04.10.23 -- 4 Ways To Strengthen Sponsor-Site Relationships For Improved Diversity 4/10/2023
    04/10/23 Clinical Leader Newsletter